April 19, 2022 | New Brunswick, NJ

The Board of Directors of Johnson & Johnson has declared a regular quarterly dividend of $1.13 per common share, an increase of approximately 6.6% over the previous quarterly dividend.

Year to date, this marks the twelfth dividend change for the Washington Crossing Advisors Rising Dividend portfolio. All twelve changes were increases. The average dividend increase was 7.26% compared with December 31, 2021 indicated levels.

From the press release: “Johnson & Johnson today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share.

“In recognition of our 2021 results, strong financial position, and
confidence in the future of Johnson & Johnson, the Board of Directors has voted to
increase the quarterly dividend for the 60th consecutive year,” said Joaquin Duato,
Chief Executive Officer of the company.

At the new rate, the indicated dividend on an annual basis is $4.52 per
share compared to the previous rate of $4.24 per share. The next quarterly dividend
is payable on June 7, 2022 to shareholders of record as of the close of business on
May 24, 2022. The ex-dividend date is May 23, 2022.”¹

About the company: “At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.”¹

---

IMPORTANT DISCLOSURES: The securities discussed herein do not represent all of the securities held by the WCA Rising Dividend Portfolio as of the date presented and are subject to change at any time, without notice. A complete list of holdings as of the date noted above will be provided upon request. The above is presented to illustrate the application of the strategy only and not intended as personalized recommendations of any particular security. The securities identified and described above do not represent all of the securities purchased, sold, or recommended for client accounts. You should not assume that an investment in any of the securities identified was or will be profitable. Changes in market conditions or a company’s financial condition may impact the company’s ability to continue to pay dividends. Companies may also choose to discontinue dividend payments. All investments involve risk, including loss of principal, and there is no guarantee that investment objectives will be met. It is important to review your investment objectives, risk tolerance and liquidity needs before choosing an investment style or manager. Equity investments are subject generally to market, market sector, market liquidity, issuer, and investment style risks, among other factors to varying degrees. Fixed Income investments are subject to market, market liquidity, issuer, investment style, interest rate, credit quality, and call risks, among other factors to varying degrees.